What is the recommended dosing of vancomycin for patients undergoing Sustained Low-Efficiency Dialysis (SLED)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vancomycin Dosing in SLED

For patients on SLED, administer a loading dose of 2400 mg followed by maintenance doses of 1600 mg daily, with mandatory therapeutic drug monitoring to guide subsequent dosing due to highly variable clearance. 1

Loading Dose Strategy

  • Administer 2400 mg as a loading dose to rapidly achieve therapeutic concentrations in critically ill patients receiving SLED 1
  • Alternatively, a weight-based loading dose of 25-30 mg/kg can be used in critically ill patients, infused over 2 hours with antihistamine premedication to minimize red man syndrome risk 2
  • Loading doses are essential because SLED significantly removes vancomycin from the circulation 1, 3, 4

Maintenance Dosing

  • Give 1600 mg daily as the empiric maintenance dose based on pharmacokinetic modeling that achieves target AUC/MIC ≥400 while maintaining AUC24 <700 to minimize nephrotoxicity risk 1
  • SLED removes approximately 35-42% of vancomycin during an 8-hour session, with the greatest removal occurring in the first 4 hours 3, 4, 5
  • Vancomycin clearance during SLED is highly variable, averaging 5.97 L/h on SLED versus 2.40 L/h off SLED 1

Post-SLED Supplementation

  • Redose with at least 500-1000 mg after each SLED session if pre-dialysis levels are 20-30 mcg/mL, as serum concentrations drop below therapeutic range (<15 mcg/mL) in nearly half of patients by the end of an 8-hour session 3, 4
  • Vancomycin rebound after SLED is minimal (approximately 9.8%), so additional dosing is required immediately post-SLED rather than waiting for redistribution 4

Therapeutic Drug Monitoring Requirements

  • Obtain trough levels before the fourth dose to confirm steady-state, then monitor before each SLED session and after dose adjustments 6, 7
  • Target trough concentrations of 15-20 mg/L for serious infections to achieve AUC/MIC ≥400 for organisms with MIC ≤1 mg/L 6, 7, 2
  • Monitor serum creatinine at least twice weekly throughout therapy, as sustained trough concentrations >20 μg/mL increase nephrotoxicity risk 6, 2

Management of Elevated Levels

  • Immediately hold the next dose when trough exceeds 20 mg/L and recheck levels before administering subsequent doses 6, 7, 2
  • Once trough decreases to 15-20 mg/L, resume vancomycin at reduced dose or extend dosing interval by approximately 15-20% 6

Critical Considerations

  • SLED clearance of vancomycin is 3-fold higher than continuous renal replacement therapy, requiring more aggressive dosing strategies 5
  • The vancomycin half-life during SLED is approximately 13.6 hours with minimal rebound after dialysis completion 4
  • Switch to alternative antibiotics when vancomycin MIC ≥2 mg/L, as target AUC/MIC ratios are not achievable with conventional dosing 6, 7, 2

Common Pitfalls to Avoid

  • Never use fixed-dose maintenance regimens without therapeutic drug monitoring, as they fail to reach target levels in the majority of SLED patients 3, 8
  • Do not rely on dosing recommendations from intermittent hemodialysis or continuous renal replacement therapy, as SLED pharmacokinetics differ significantly 4, 5
  • Avoid monitoring only peak levels, as trough monitoring is the most accurate and practical method for guiding vancomycin dosing 6, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.